Search
CoVac-1
go.drugbank.com/drugs/DB16429InvestigationalSponsored by the University Hospital Tuebingen in Germany, CoVac-1 is a multi-peptide COVID-19 vaccine candidate created from HLA class I and HLA-DR T-cell epitopes of the S-protein[A226588]. … It is being investigated in the clinical trial NCT04546841 (Safety and Immunogenicity Trial of Multi-peptide Vaccination to Prevent COVID-19 Infection in Adults (pVAC))[L30428] and aims to induce broad
Panobacumab
go.drugbank.com/drugs/DB15342InvestigationalPanobacumab is under investigation in clinical trial NCT00851435 (Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa).
Northern bluefin tuna
go.drugbank.com/drugs/DB14162ApprovedNorthern bluefin tuna allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic ExtractBetula lenta whole
go.drugbank.com/drugs/DB14164ApprovedBetula lenta whole allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic ExtractCulex pipiens
go.drugbank.com/drugs/DB14165ApprovedCulex pipiens allergenic extract is used in allergenic testing.
Categories: Non-Standardized Insect Allergenic ExtractRumex acetosella whole
go.drugbank.com/drugs/DB14166ApprovedWithdrawnRumex acetosella whole allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic ExtractRumex crispus top
go.drugbank.com/drugs/DB14167ApprovedWithdrawnRumex crispus top allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic ExtractSalix nigra bark
go.drugbank.com/drugs/DB14169ApprovedWithdrawnSalix nigra bark allergenic extract is used in allergenic testing.
Categories: Non-Standardized Food Allergenic ExtractSchinus terebinthifolia pollen
go.drugbank.com/drugs/DB21762ApprovedSchinus terebinthifolia pollen is the pollen of the Schinus terebinthifolia plant. Schinus terebinthifolia pollen is mainly used in allergenic testing.
Categories: Non-Standardized Pollen Allergenic ExtractLX201
go.drugbank.com/drugs/DB04943InvestigationalIt is being developed by Lux Biosciences, Inc. … LX201 is a silicone matrix ocular implant that provides sustained release of cyclosporine A (CsA) locally to the eye over the course of one year.